Published in
American Association for the Advancement of Science, Science Translational Medicine, 571(12), 2020
DOI: 10.1126/scitranslmed.abd6169
Links
Tools
Antitumor activity without on-target off-tumor toxicity of GD2–chimeric antigen receptor T cells in patients with neuroblastoma
Journal article published in 2020 by
Karin Straathof 
,
Barry Flutter ,
Rebecca Wallace,
Neha Jain ,
Thalia Loka ,
Sarita Depani,
Gary Wright,
Simon Thomas ,
Gordon Weng-Kit Cheung ,
Talia Gileadi ,
Sian Stafford ,
Evangelia Kokalaki ,
Jack Barton ,
Clare Marriott,
Dyanne Rampling
and other authors.
,
Barry Flutter ,
Rebecca Wallace,
Neha Jain ,
Thalia Loka ,
Sarita Depani,
Gary Wright,
Simon Thomas ,
Gordon Weng-Kit Cheung ,
Talia Gileadi ,
Sian Stafford ,
Evangelia Kokalaki ,
Jack Barton ,
Clare Marriott,
Dyanne Rampling
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Patients with neuroblastoma infused with GD2-directed CAR-T cells experienced immune activation and transient tumor regressions without neurotoxicity.